The Supreme Court and, subsequently, the Italian Budget Law 2024, have extended the participation exemption regime to non-resident companies without a permanent establishment in Italy, provided they are in an EU or EEA state. This note describes the implications of the new provision.
No takes yet. Share an insight, caveat, or question.
Marco Ferrari (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: